rs375343071
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_173728.4(ARHGEF15):c.266C>A(p.Thr89Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000692 in 1,560,656 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T89T) has been classified as Likely benign.
Frequency
Consequence
NM_173728.4 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_173728.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARHGEF15 | NM_173728.4 | MANE Select | c.266C>A | p.Thr89Asn | missense | Exon 2 of 16 | NP_776089.2 | ||
| ARHGEF15 | NM_025014.2 | c.266C>A | p.Thr89Asn | missense | Exon 2 of 16 | NP_079290.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ARHGEF15 | ENST00000361926.8 | TSL:1 MANE Select | c.266C>A | p.Thr89Asn | missense | Exon 2 of 16 | ENSP00000355026.3 | ||
| ARHGEF15 | ENST00000421050.2 | TSL:1 | c.266C>A | p.Thr89Asn | missense | Exon 2 of 16 | ENSP00000412505.1 | ||
| ARHGEF15 | ENST00000579439.5 | TSL:5 | c.266C>A | p.Thr89Asn | missense | Exon 2 of 3 | ENSP00000464540.1 |
Frequencies
GnomAD3 genomes AF: 0.000154 AC: 23AN: 149774Hom.: 0 Cov.: 28 show subpopulations
GnomAD2 exomes AF: 0.0000424 AC: 9AN: 212278 AF XY: 0.0000177 show subpopulations
GnomAD4 exome AF: 0.0000602 AC: 85AN: 1410882Hom.: 3 Cov.: 36 AF XY: 0.0000488 AC XY: 34AN XY: 697116 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000154 AC: 23AN: 149774Hom.: 0 Cov.: 28 AF XY: 0.0000685 AC XY: 5AN XY: 72990 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.266C>A (p.T89N) alteration is located in exon 2 (coding exon 1) of the ARHGEF15 gene. This alteration results from a C to A substitution at nucleotide position 266, causing the threonine (T) at amino acid position 89 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Developmental and epileptic encephalopathy Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 89 of the ARHGEF15 protein (p.Thr89Asn). This variant is present in population databases (rs375343071, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with ARHGEF15-related conditions. ClinVar contains an entry for this variant (Variation ID: 403967). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The asparagine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at